GeneBio and the Swiss Institute of Bioinformatics Unveil Latest Edition of the Melanie Platform

Geneva, Switzerland - February 8, 2008 - Geneva Bioinformatics (GeneBio) SA and the Swiss Institute of Bioinformatics (SIB) today announced the release of a new version of the renowned Melanie 2-D gel analysis platform. Version 7.0 of Melanie offers an entirely revised user interface and user interaction modes that streamline the analysis process, resulting in major usability and speed improvements that greatly facilitate the completion of both simple and complex tasks as well as high throughput analysis.

Melanie is developed by the SIB and GeneBio in collaboration with GE Healthcare and is a recognized leader in the field of two-dimensional gel electrophoresis analysis strengthened by an active 20-year presence in the market. It offers a unique and flexible interface for the comprehensive visualization, exploration and analysis of 2-D gel data from both DIGE (Fluorescence Difference Gel Electrophoresis) and non-DIGE technologies.

This novel version of Melanie grandly improves the way researchers analyze their 2-D electrophoresis gels to identify protein markers of interest. It avoids inaccuracies due to manual spot editing and minimizes repetitive match editing tasks. It helps reduce time spent finding significant protein expression changes and increases the reliability of the results, thus improving the chances for proteomics professionals to achieve their research objectives.

Thanks to the collaboration between GeneBio and GE Healthcare, this new version 7.0 will be commercialised by GeneBio and GE Healthcare under the names Melanie and ImageMaster 2D Platinum respectively. GeneBio will demonstrate this latest release at the upcoming ABRF meeting in February (booth n° 219). Please visit us at the conference or go to www.2d-gel-analysis.com to learn more about this new version and the wealth of advanced features it presents.

"We are very excited with this new product launch as it fits perfectly with our other existing products and continues our long-term relationships with the SIB and GE Healthcare," said Nasri Nahas, CEO of GeneBio. "Melanie has been part of our portfolio for a number of years and customers return again and again to this industry standard. This new release is a testimony to the three parties' continued and reinforced commitment to the 2-D gel analysis field. We are very happy to be part of Melanie and ImageMaster Platinum's history and believe that this latest version will contribute to the product's reputation as an industry-leading platform."

"The Swiss Institute of Bioinformatics is proud of this latest iteration of Melanie and confident in our ongoing development efforts with the teams at GeneBio and GE Healthcare," said Ron D. Appel, Director of the SIB. "Melanie has been around since 1984 and continues to stay on the cutting edge of 2-D gel analysis; this is a testament to both the quality of the product and the innovative developments required to keep the platform at the top of its class. The SIB is committed to remaining a key player in this field and we look forward to a long and distinguished future for Melanie."

About GeneBio
Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company providing the life science community with world-class proteomics software that bridges the gap between information gathering and knowledge generation. Established in 1997, we focus our expertise on protein identification and characterization as well as proteome imaging, offering clients and partners a high degree of specialization essential to proteomics research. Close ties to academic peers and a thorough network of distribution and strategic partners give us both unfettered access to scientific excellence and recognized market presence so that we may best serve the scientific community.

About The Swiss Institute of Bioinformatics (SIB)
The SIB is an academic not-for-profit foundation established on March 30, 1998 whose mission is to promote research, the development of databases and computer technologies, teaching and service activities in the field of bioinformatics, in Switzerland with international collaborations. For more information about the SIB, please visit: www.isb-sib.ch.

GeneBio contact:
Mr. Andrew Smith
Marketing Manager
andrew.smith@genebio.com
Tel. +41.22.702.99.00

Swiss Institute of Bioinformatics contact:
Dr. Beatrice Bressan
Head, Communications
beatrice.bressan@isb-sib.ch

###